Tekla Life Sciences Investors
Tekla Life Sciences Investors (HQL) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HQL · as of Jun 8, 2026
Key Statistics
Explore Tekla Life Sciences Investors Data
hql stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
hql competitorsHQL
CCAP
CION
ECC
GAIN
GIGStock Performance
Full HistoryAbout Tekla Life Sciences Investors
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest …
what is tekla life sciences investors · hql stock overview · tekla life sciences investors company profile · who is tekla life sciences investors ceo · hql NYSE · tekla life sciences investors headquarters · tekla life sciences investors business segments
About Stock Overview & Key Data
Tekla Life Sciences Investors (HQL) is a Financial Services company in the Asset Management industry, listed on NYSE since May 1, 1992. As of the latest trading session, HQL stock price is $16.92, with a market capitalization of $514.5M. The stock has returned +32.19% over the past 12 months and +0.83% year-to-date.
In fiscal year 2025, Tekla Life Sciences Investors reported revenue of $86.4M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Tekla Life Sciences Investors (HQL) stock price is $16.92. The stock is traded on NYSE under the ticker symbol HQL. The 52-week range is $12.34 – $18.46.